Microvascular reactivity in patients with hypercholesterolemia: the effect of lipid lowering treatment

Title:

Microvascular reactivity in patients with hypercholesterolemia: the effect of lipid lowering treatment

Creator:

Tomáš Štulc, Zdislava Kasalová, Martin Prázný, Michal Vrablík, Jan Škrha, and Richard Češka

Identifier:

https://cdk.lib.cas.cz/client/handle/uuid:59ce527e-5aba-4d0c-856e-dfea81475b93
uuid:59ce527e-5aba-4d0c-856e-dfea81475b93
issn:0862-8408

Subject:

Fyziologie člověka a srovnávací fyziologie, hypercholesterolémie, endoteliální dysfunkce, hypercholesterolemia, endothelial dysfunction, microcirculation, cholesterol lowering, laser-doppler, 14, and 612

Type:

article, články, model:article, and TEXT

Format:

print, bez média, and svazek

Description:

Impaired NO-dependent vasodilation of resistance vessels is an early marker of an increased risk of atherosclerosis; utility of the examination of microcirculation, however, is far less established. We have therefore tested the hypothesis that hypercholesterolemia is associated with an impaired microvascular reactivity and that this defect is at least partially reversible by lipid-lowering treatment. Twenty-seven otherwise healthy patients with severe hypercholesterolemia (HLP) were examined at rest and then after 10 weeks of atorvastatin treatment (20 mg/day). Skin microvascular reactivity (MVR) was examined by laser-Doppler flowmetry. Baseline MVR values of the studied group were compared to healthy control subjects, HLP patients with coronary artery disease (CAD) and diabetic patients with and without diabetic retinopathy. MVR was normal in HLP subjects without CAD. On the contrary, MVR was impaired in HLP patients with CAD. There was no effect of atorvastatin on MVR, despite the profound reduction of serum lipids. MVR values did not correlate with cholesterol levels. In diabetic subjects, the MVR was substantially impaired only in patients with retinopathy. In the subjects without retinopathy, MVR was either normal (type I diabetes) or moderately impaired (type II diabetes). MVR was thus normal in HLP patients without manifest vascular disease and was not influenced by lipid lowering therapy. Impairment in the MVR was only evident in subjects with HLP and severe CAD. These results suggest that microcirculation is not involved in the early vascular dysfunction induced by HLP and that MVR rather reflects changes which appear later in the course of the atherosclerotic disease., T. Štulc, Z. Kasalová, M. Prázný, M. Vrablík, J. Škrha, R. Češka., and Obsahuje bibliografii

Language:

English

Rights:

http://creativecommons.org/licenses/by-nc-sa/4.0/
policy:public

Source:

Physiological research | 2003 Volume:52 | Number:4

Harvested from:

CDK

Metadata only:

false